The Trump Administration’s final Most Favored Nation executive order will have a significant and negative impact on American patients because it imposes destructive foreign price control policies over both Medicare Part B and Part D prescription drugs. This will unravel an important program that millions of patients depend on especially during the COVID-19 crisis. This EO will also stifle American medical innovation including new treatments and a vaccine for COVID-19. –